Mid-regional pro-adrenomedullin is a novel biomarker for arterial stiffness as the criterion for vascular failure in a cross-sectional study

We investigated the potential of mid-regional pro-adrenomedullin (MR-proADM) for use as a novel biomarker for arterial stiffness as the criterion for vascular failure and cardiometabolic disease (obesity, hypertension, dyslipidemia, diabetes, and metabolic syndrome) compared with high-sensitivity C-...

Descripción completa

Detalles Bibliográficos
Autores principales: Koyama, Teruhide, Kuriyama, Nagato, Suzuki, Yosuke, Saito, Satoshi, Tanaka, Ryota, Iwao, Motoshi, Tanaka, Megumu, Maki, Takakuni, Itoh, Hiroki, Ihara, Masafumi, Shindo, Takayuki, Uehara, Ritei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801498/
https://www.ncbi.nlm.nih.gov/pubmed/33431996
http://dx.doi.org/10.1038/s41598-020-79525-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801498/
https://www.ncbi.nlm.nih.gov/pubmed/33431996
http://dx.doi.org/10.1038/s41598-020-79525-2

Ejemplares similares